Read More

iRhythm Technologies Shares Preliminary Q4 2023 Highlights And Business Update At The 42nd Annual J.P. Morgan Healthcare Conference; Grew Q4 2023 Patient Registrations In Excess Of 22% YoY; Sees FY24 Revenue $575M-$585M Vs 578.72M Est.

iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational

IRTC